This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Agilent Technologies, Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Innovations of Jennifer Lapira in DNA Polymerase Technology
Introduction
Jennifer Lapira is an accomplished inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of DNA polymerases. Her work focuses on enhancing the efficiency and effectiveness of polymerase enzymes used in various applications.
Latest Patents
Jennifer holds a patent for "Thermostable type-A DNA polymerase mutants with increased polymerization rate and resistance to inhibitors." This invention provides mutants of DNA polymerases that exhibit an increased rate of nucleotide incorporation into nucleic acids during polymerization. Additionally, these mutants demonstrate enhanced resistance to inhibitors that typically affect DNA polymerase activity. The mutant polymerases are particularly well-suited for fast PCR applications, enabling the amplification of targets in samples that contain inhibitors of wild-type polymerases. In exemplary embodiments, the mutants are derived from Taq DNA polymerase.
Career Highlights
Jennifer is currently employed at Agilent Technologies, Inc., where she continues to innovate in the field of molecular biology. Her work has implications for various applications, including diagnostics and research, where rapid and reliable DNA amplification is crucial.
Collaborations
Jennifer collaborates with talented colleagues, including Holly Hogrefe and Michelle H Cayouette, who contribute to her research and development efforts.
Conclusion
Jennifer Lapira's contributions to DNA polymerase technology exemplify the impact of innovative thinking in biotechnology. Her patented work enhances the capabilities of PCR applications, paving the way for advancements in genetic research and diagnostics.